Home / Resource Library / Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia

Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia

Study examined mechanisms for treatment resistance to pirtobrutinib for CLL.